JESSICA JONES: Open Payments
NPI 1285305409 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 46 payments from 16 companies in 2025. Trend: 2023 $708 · 2024 $1,019 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $423 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $147 |
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| PFIZER INC. | 4 | $91 |
| TOLMAR, INC. | 4 | $75 |
| Lilly USA, LLC | 2 | $37 |
| Amgen Inc. | 2 | $28 |
| Boston Scientific Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: VRAYLAR, Kerendia, QULIPTA, UBRELVY, FARXIGA, NURTEC ODT, JATENZO, BREZTRI.
Industry payments across VA — which companies pay providers there.
